Variscan Mines Limited (ASX: VAR), a zinc-lead explorer operating the Novales Project in northern Spain, has confirmed the successful settlement and allotment of the second tranche of its $5 million capital raise, completing the full placement as announced on 11 May 2026. The second tranche, which required and received shareholder approval at a General Meeting held on 10 July 2026, raised approximately $4.31 million before costs through the issue of more than one billion ordinary shares at $0.004 per share. Alongside the completion of the placement, shareholders also approved a proposed name change to Altoro Metals Limited, signalling a potential strategic repositioning for the company as it advances its Spanish exploration assets.
Key Points
- Variscan Mines Limited (ASX: VAR) has completed the full $5 million placement, with both tranches now settled and allotted
- Tranche 2 raised approximately $4.31 million before costs via 1,075,935,292 ordinary shares at $0.004 per share, following shareholder approval at the 10 July 2026 General Meeting
- Directors participated in the Tranche 2 raise to the value of $0.6 million; 416,666,666 Lead Manager Options were also approved, exercisable at $0.008 each on or before 29 September 2028
- Shareholders approved a proposed name change to Altoro Metals Limited, which will take effect once all statutory approvals are met
- Investors should watch for completion of the statutory name-change process and any announcement regarding deployment of the $5 million in proceeds toward the Novales Project in Spain
Full $5 Million Placement Completed Across Two Tranches at $0.004 Per Share
Variscan Mines has confirmed that the second and final tranche of its $5 million placement has now settled and allotment has been completed, bringing the total capital raise to its full intended size. The placement was originally announced on 11 May 2026, with Tranche 1 settling shortly after, raising approximately $0.69 million before costs through the issue of 174,064,708 ordinary shares at a price of $0.004 per share. That first tranche was supported by a number of new sophisticated and professional investors, reflecting what the company described as well-supported interest in the offer.
The second tranche, which raised approximately $4.31 million before costs, required shareholder approval given the scale of share issuance involved and the participation of company directors. Approval was received at the General Meeting held on 10 July 2026, after which the allotment of 1,075,935,292 ordinary shares at the same $0.004 per share price was completed. In aggregate, the two tranches combined to raise the full $5 million before costs, with the total shares issued across both tranches amounting to 1,250,000,000 ordinary shares. All shares issued under the placement rank equally with Variscan's existing fully paid ordinary shares as of the date of the company update.
Director Participation of $0.6 Million Signals Board Confidence in Variscan's Strategy
A notable feature of the Tranche 2 placement was the participation by the company's directors, who collectively subscribed to $0.6 million worth of shares as part of the raise. Director participation in a placement is generally viewed as a signal of internal confidence in the company's direction and the value represented by the issue price, though investors should independently assess this alongside other publicly available information. The company did not disclose further details regarding which individual directors participated or the specific breakdown of their respective contributions in this company update.
Director participation required shareholder approval under ASX Listing Rules, which was duly sought and obtained at the 10 July 2026 General Meeting. All resolutions put to shareholders at that meeting were passed, enabling the full completion of the placement. The involvement of directors in the raise at the same price as external sophisticated and professional investors means that the board has taken on exposure to Variscan's performance at the $0.004 per share level, aligning their interests to some degree with those of incoming investors. This structure is a common practice among junior explorers seeking to demonstrate board conviction when undertaking capital raises.
Shareholder Approval of 416,666,666 Lead Manager Options Exercisable at $0.008 Each
In addition to approving the Tranche 2 share issuance, shareholders at the 10 July 2026 General Meeting also voted to approve the issue of 416,666,666 Lead Manager Options. These options are exercisable at any time on or before 29 September 2028, with each option exercisable by payment of $0.008. The exercise price of $0.008 represents a 100% premium to the $0.004 per share placement price, meaning the options would only be exercised if Variscan's share price trades above that threshold at some point before the expiry date.
Lead Manager Options are a standard form of remuneration for brokers and financial intermediaries who assist companies in placing shares with investors. Should all 416,666,666 options be exercised, this would bring additional capital into the company but would also result in further dilution to existing shareholders. Investors should factor the potential impact of these options into their assessment of the company's capital structure. The company did not disclose the identity of the Lead Manager in this company update, nor did it provide further information about the specific services rendered in connection with the placement.
Shares Issued to Feldi Limited in Lieu of Fees Following General Meeting Approval
The General Meeting on 10 July 2026 also approved the issue of 16,875,000 ordinary shares to Feldi Limited in lieu of fees. These shares were issued on the same terms as the placement shares, meaning they were issued at $0.004 per share and rank equally with all other fully paid ordinary shares on issue. The structure of issuing shares in lieu of cash fees is a common approach for smaller listed companies seeking to preserve cash while compensating service providers or advisers with equity.
The company did not provide further detail in this company update about the nature of the services provided by Feldi Limited or the total fee value represented by the 16,875,000 shares. At the placement price of $0.004 per share, the implied value of this share parcel would amount to $67,500, though this figure is a calculation based on the disclosed placement price and is not a figure separately stated by the company. Investors with questions about the nature of Feldi Limited's engagement or its role with Variscan are encouraged to consult the company directly or review supplementary filings on the ASX platform.
Proposed Name Change to Altoro Metals Limited Approved by Shareholders
One of the more strategically significant outcomes of the 10 July 2026 General Meeting was shareholder approval for a proposed change of the company's name from Variscan Mines Limited to Altoro Metals Limited. The company stated in the update that the name change will take effect in due course and once all statutory approvals have been met. No specific timeline was provided for when the rebrand would formally come into effect, and the ASX ticker code change, if any, was not addressed in the company update.
Name changes for ASX-listed companies often accompany shifts in strategic focus, project portfolio, or marketing positioning, and investors may be watching for further communications about what the Altoro Metals brand is intended to convey about the company's direction. The company has not disclosed, in this company update, the specific rationale behind the name change beyond the shareholder approval notice. Until statutory processes are finalised, the company will continue to operate and be identified on the ASX as Variscan Mines Limited under the ticker VAR.
Novales Zinc-Lead Project in Northern Spain Remains the Core Asset Underpinning the Raise
Variscan Mines' primary asset is the Novales Project, located in the Basque-Cantabrian Basin approximately 30 kilometres southwest of Santander in northern Spain. The project is centred on the former producing San Jose underground mine, which is surrounded by a large area offering exploration opportunities. These include a number of satellite underground and surface workings, as well as areas of zinc anomalism identified through recent and historical geochemical surveys. Variscan has delineated a significant 12-kilometre mineralised trend and a sub-parallel 3-kilometre trend from both contemporary and historical data across the Buenahora exploration and Novales mining permits.
The Novales Project benefits from proximity to significant regional infrastructure and geological precedent. The San Jose Mine is located approximately nine kilometres from the world-class Reocin Mine, which is recognised as the largest known strata-bound carbonate-hosted zinc-lead deposit in Spain and one of the world's richest MVT (Mississippi Valley-Type) deposits. The project is also within approximately 80 kilometres trucking distance of the San Juan de Nieva zinc smelter operated by Asturiana de Zinc, which is 100 per cent owned by Glencore. This proximity to established smelting infrastructure could be a meaningful logistical advantage should the project advance toward production, though the company is presently at the exploration stage.
Geological Credentials Supporting the Novales Project's Exploration Potential
The technical work underpinning the Novales Project is overseen by Dr. Mike Mlynarczyk, Principal of Redstone Exploration Services, an external geological consultancy engaged by Variscan. Dr. Mlynarczyk holds credentials as a Professional Geologist (PGeo) with the Institute of Geologists of Ireland, a European Geologist (EurGeol) with the European Federation of Geologists, and a Fellow of the Society of Economic Geologists. The company has confirmed that Dr. Mlynarczyk qualifies as a Competent Person as defined in the December 2012 edition of the JORC Code, the industry-standard framework for reporting exploration results, mineral resources, and ore reserves in Australia.
The Novales Project includes a number of granted mining tenements, providing the company with a degree of regulatory certainty over its exploration ground. The project's geological setting within the Basque-Cantabrian Basin is considered prospective for the style of zinc-lead mineralisation that has historically yielded significant deposits in the region. Investors may note that while the historical geological context is encouraging, the company is currently an explorer and has not disclosed mineral resource estimates or production timelines in this company update. The information relating to previous exploration results was prepared pre-2012 JORC code, and Variscan has stated that while some data may be incomplete, nothing has come to its attention that calls into question the accuracy or reliability of the historical exploration data.
Capital Structure Implications of the $5 Million Raise for Existing Variscan Shareholders
The completion of the full $5 million placement has resulted in a significant increase in Variscan's total shares on issue. Across Tranche 1 and Tranche 2, a combined total of 1,250,000,000 ordinary shares were issued at $0.004 each, in addition to the 16,875,000 shares issued to Feldi Limited under the fee arrangement. Furthermore, the 416,666,666 Lead Manager Options, if exercised in full before 29 September 2028, would bring additional shares onto the register. The aggregate effect of these issuances represents a material expansion of the company's share count, which has dilutive implications for existing shareholders who did not participate in the placement.
Junior explorers frequently undertake placements of this nature to fund ongoing exploration programs, maintain working capital, and meet the costs of operating as a listed entity. The company did not provide a specific breakdown of how the $5 million in proceeds will be deployed across its activities in this company update. Investors may wish to review prior announcements and the company's investor communications for any previously disclosed use-of-funds statements relating to this raise. The immediate share price impact was not clear from available public information at the time of this report.
Key Risks Facing Variscan as an Early-Stage Zinc Explorer in Spain
As an early-stage mineral explorer with its primary asset located in Spain, Variscan faces a range of risks that investors should consider carefully. Exploration-stage companies by definition carry higher risk than producers, as there is no guarantee that exploration activities will result in the delineation of a commercially viable mineral resource. The Novales Project, while geologically prospective, has not yet advanced to a resource estimate stage as disclosed in publicly available company updates, and the timeline to any potential production is uncertain and subject to numerous regulatory, technical, and financial hurdles.
Operating in a foreign jurisdiction introduces additional risks including changes to Spanish or European Union mining regulations, foreign exchange exposure between Australian dollars and euros, and the logistical and administrative complexities of managing exploration activities from Australia. The substantial capital raising undertaken by Variscan, while providing near-term funding, has also meaningfully increased the company's share count, which could weigh on the share price if the market perceives the dilution as unfavourable relative to the value created. The proposed name change to Altoro Metals Limited, while shareholder-approved, also introduces a period of transition that may require market re-familiarisation with the company's identity and strategy.





Please wait processing your request...